PDR001 Plus Imatinib for Metastatic or Unresectable GIST
Clinical trial NCT03609424 · COMPLETED
Trial details
- NCT number
- NCT03609424
- Sponsor
- Asan Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-14
- Primary completion
- 2021-11-11
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.